Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in haemodialysis patients
Christoph Wanner(Universitätsklinikum Würzburg), Jutta Passlick‐Deetjen(Fresenius Medical Care (Germany))
Cited by 69
Related Papers
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
|New England Journal of Medicine|2016|3.6k
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
|New England Journal of Medicine|2013|990
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
|The Lancet|2022|969
CKD Prevalence Varies across the European General Population
|Journal of the American Society of Nephrology|2015|588
Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
|New England Journal of Medicine|2010|574